Advocacy

Government relations and issue advocacy are more important to your company’s future than you might realize.  Far too often small companies lack the means or the experience to be heard. With hundreds of Emerging Growth Company members, AdvaMed is your advocate – fighting for the issues you care about. Learn More…

Business Development

AdvaMed members develop and manufacture nearly 90% of the $80 billion in domestic device and diagnostic products. EGCC members have senior-level access to these companies and their executives though partnering programs, company presentations and investor forums, giving you the opportunity to showcase the value of your technology. Learn More…

Education

Innovation in medical technology leads to improvements in treatment and better patient care, but your degree can only get you so far. That’s why EGCC members receive discounted access to AdvaMed’s Medical Technology Learning Institute. Built on the experience of AdvaMed’s staff specialists, members and industry experts, MTLI is the only professional education curriculum designed by industry for industry. Learn More…

Business Solutions

AdvaMed is the largest medical technology trade association in the world, and we have leveraged that that market position into our Business Solutions program.  Our solutions give our members access to innovative partners and better pricing and terms with industry-leading suppliers and professional service firms. Learn More…

Outreach

While AdvaMed works to advance the industry as a whole, we also believe it critically important to create opportunities for members to gain exposure, showcase innovation, and provide thought-leadership. Demonstrating the value of technology to key audiences is integral to maintaining and stimulating growth of our industry. AdvaMed is your voice across the country and throughout the world. Learn More…

“NovaVision was honored to be invited to participate as a small company in AdvaMed's Value of Technology showcase on Capitol Hill. The event was well-organized, well-attended, and most importantly, provided good exposure to staffers and policymakers on Capitol Hill. We have greatly benefited from this opportunity to showcase our technology. Largely as a result of the event, key policymakers have taken interest in our therapy and have joined our efforts in making the therapy more accessible.” - Holger Weiss, Vice President & Chief Financial Officer, NovaVision

“Venture capital backed startup companies who are developing and marketing truly innovative products have a major challenge in dealing with both the FDA and CMS these days.  Over the past decade, transparency of FDA processes and context to their decisions has been achieved with the help of AdvaMed.  Today, the same type of assistance is required and occurring thanks to AdvaMed with CMS.  My current company which serves the Wound Management market is additionally challenging in terms of reimbursement.  As a smaller company, I need all the help I can get and AdvaMed’s staff has worked with me as part of a larger, organized sector to address these issues.  AdvaMed can help get issues addressed that otherwise would be difficult for a company going it alone.”  - Kevin Nickels, President & Chief Executive Officer, Celleration, Inc.

“Our one hour face-to-face meeting with AdvaMed executives addressed key questions that we had been debating for a number of months.  As a non-U.S. based company, these answers saved us additional money that we would have had to spend on consultants.  Membership has already paid for itself and we are only in the first quarter of the year.” - Paul Mitchell, US Operations, Deltex Medical